Rate My Professor Olga Aroniadis

Olga Aroniadis, MD, MSc, FACG, is a tenured Professor of Medicine and the Svetlana Koroleva Endowed Professor in Gastroenterology at the Renaissance School of Medicine at Stony Brook University. She holds the position of Chief of the Division of Gastroenterology and Hepatology at Stony Brook University Hospital, Director of the Master’s Program in Epidemiology and Clinical Research within the Program of Public Health, and Founder and Director of the Gastrointestinal Women’s Health Center. Aroniadis completed her undergraduate education summa cum laude at Tufts University, earned her MD from Albert Einstein College of Medicine in 2008 with Research Distinction in Gastroenterology, and obtained her MSc in Clinical Research Methods from Albert Einstein College of Medicine in 2016. She performed her internal medicine internship, residency, and chief residency at Montefiore Medical Center, completing residency in 2012, followed by a gastroenterology fellowship at the same institution in 2015. She joined the faculty at Stony Brook University in 2019 after serving as faculty at Montefiore Medical Center from 2015 to 2019, where she received the Department of Medicine Rising Star Award and an NIH-funded KL2 career development award.

Aroniadis's research specializations include microbial therapeutics for gastrointestinal diseases such as Clostridioides difficile infection and irritable bowel syndrome. She has led investigator-initiated studies, including a randomized clinical trial on fecal microbiota transplantation for diarrhea-predominant irritable bowel syndrome. Her clinical interests encompass disorders of gut-brain interaction and gastrointestinal health as it relates to women. She is board certified in internal medicine and gastroenterology by the American Board of Internal Medicine. Aroniadis contributes significantly to professional organizations, serving on the American College of Gastroenterology Educational Affairs Committee, as Course Director for the biannual ACG Imaging and Pathology Course, and as Chair of the Executive Committee of the Rome Foundation Partners Program in her role as U.S. lead. Her key publications include "Medical Cannabis Use Patterns and Adverse Effects in Inflammatory Bowel Disease" (2023), "Association Between Preadmission Acid Suppressive Therapy and Clinical Outcomes in Acute Pancreatitis" (2021), "Very low incidence of Clostridioides difficile infection in patients with sickle cell disease" (2020), and "Microbiome predictors of dysbiosis and VRE bacteremia in patients undergoing allo-HSCT" (2019). She mentors medical students, residents, and fellows in the Department of Medicine.